Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk

by Einarsdottir, K., Humphreys, K., Hall, P., Wedren, S., Bonnard, C., Li, Y., Liu, E.T., Liu, J., Li, Y., Chia, K.S.
Published 2011

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study

by Einarsdóttir, K, Rylander-Rudqvist, T, Humphreys, K, Ahlberg, S, Jonasdottir, G, Weiderpass, E, Chia, K.S, Ingelman-Sundberg, M, Persson, I, Liu, J, Hall, P, Wedrén, S
Published 2020

Linkage disequilibrium mapping of CHEK2: Common variation and breast cancer risk

by Einarsdottir, K., Humphreys, K., Palmgren, J., Sjolander, A., Hall, P., Wedren, S., Bonnard, C., Li, Y., Liu, E.T., Liu, J., Iles, M.M., Chia, K.S.
Published 2011

Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: A population-based case-control and follow-up study

by Einarsdóttir, K., Rosenberg, L.U., Humphreys, K., Bonnard, C., Palmgren, J., Li, Y., Li, Y., Chia, K.S., Liu, E.T., Hall, P., Liu, J., Wedrén, S.
Published 2014

ESR1 and EGF genetic variation in relation to breast cancer risk and survival

by Einarsdóttir, K, Darabi, H, Li, Y, Low, Y.L, Li, Y.Q, Bonnard, C, Sjölander, A, Czene, K, Wedrén, S, Liu, E.T, Hall, P, Humphreys, K, Liu, J
Published 2020

Genetic variants in ER cofactor genes and endometrial cancer risk

by Li, Y., Low, H.-Q., Foo, J.N., Darabi, H., Einarsdöttir, K., Humphreys, K., Spurdle, A., Easton, D.F., Thompson, D.J., Dunning, A.M., Pharoah, P.D.P., Czene, K., Chia, K.S., Hall, P., Liu, J.
Published 2014

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer

by Li, Y., Li, Y., Wedrén, S., Li, G., Charn, T.H., Desai, K.V., Bonnard, C., Czene, K., Humphreys, K., Darabi, H., Einarsdóttir, K., Heikkinen, T., Aittomäki, K., Blomqvist, C., Chia, K.S., Nevanlinna, H., Hall, P., Liu, E.T., Liu, J.
Published 2014